Experimental obesity drug outperforms traditional weight-loss treatments in early research
A new weight-loss drug shows promise in early trials. Research from the Helmholtz Institute for Diabetes and Obesity in Munich, Germany, published in the journal Nature, tested an experimental obesity and diabetes drug called GLP-1-GIP-Lani. The drug combines GLP-1 and GIP (two natural hormones that help regulate appetite and blood sugar, similar to popular weight-loss…